Researchers have demonstrated the safety of using high field strength magnetic resonance imaging (MRI) with the 11.7 tesla (T ...

The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available ...

With the platform HoloSNS — created by Professor of Biomedical Engineering Cameron McIntyre and his team — physicians and ...

Mild repetitive head injuries do more than just cause short-term issues with cognition, behavior and motor skills. They also ...

Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET. Company Participants. Katie Hogan - Senior Director-Corporate Communications and Investo ...

Neurological disease diagnosis is one of the most significant challenges faced by modern clinics due to the complexity of the nervous system and the ...

People with obstructive sleep apnea have an increased risk of Parkinson's disease, but if started early enough, continuous ...

This recent study highlights the neuroprotective potential of TFE3, a transcription factor that plays a pivotal role in counteracting key pathological mechanisms associated with Parkinson's disease ...

Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.

Sleep problems in Parkinson disease are highly prevalent, with over 80% of patients reporting sleep disturbances and insomnia.

The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...

The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in ...